Cognitive impairment in incident, untreated Parkinson disease
Top Cited Papers
- 31 March 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 72 (13) , 1121-1126
- https://doi.org/10.1212/01.wnl.0000338632.00552.cb
Abstract
Background: Little is known regarding the cognitive impairment in subjects with early, drug-naïve Parkinson disease (PD). The aim of this study was to explore the proportion with mild cognitive impairment (MCI) and subtypes in an incidence cohort of untreated PD in Southern and Western Norway. Methods: A total of 196 non-demented, drug-naive patients who were recruited after an extensive search of all new cases of PD in the area and 201 healthy control subjects completed a battery of neuropsychological tests of verbal memory, visuospatial, and attentional-executive functioning. Subjects were classified as MCI if the age- and education-corrected z-score was falling 1.5 standard deviations below the mean for at least one of the cognitive domains. Results: The PD group was more impaired on all neuropsychological tests than controls, but the effect sizes were small. The largest effect size was found for verbal memory. A total of 18.9% of the patients with PD were classified as MCI, with a relative risk of 2.1 (1.2–3.6) in PD compared to the control group. Patients with PD with and without MCI did not differ significantly regarding demographic and motor features. Among PD-MCI patients, nearly two-thirds had a non-amnestic MCI subtype, and one third had an amnestic MCI subtype. Conclusions: The findings demonstrate a twofold increase in the proportion with cognitive impairment in subjects with early, untreated Parkinson disease (PD) compared to controls. This has implications for diagnosis and management of PD. AD = Alzheimer disease; aMCI-MD = amnestic multiple-domain MCI; aMCI-SD = amnestic single-domain MCI; CVLT-2 = California Verbal Learning Test II; IQCode = Informant Questionnaire on Cognitive decline in the elderly; MADRS = Montgomery and Aasberg Depression Rating Scale; MCI = mild cognitive impairment; MMSE = Mini-Mental State Examination; naMCI-MD = non-amnestic multiple-domain MCI; naMCI-SD = non-amnestic single-domain MCI; PD = Parkinson disease; RR = relative risks; UPDRS = Unified Parkinson’s Disease Rating Scale; VOSP = Visual Object and Space Perception Battery.Keywords
This publication has 26 references indexed in Scilit:
- Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2007
- The Unified Parkinson's Disease Rating Scale: Validation study of the mentation, behavior, and mood sectionMovement Disorders, 2007
- Patterns of Atrophy Differ Among Specific Subtypes of Mild Cognitive ImpairmentArchives of Neurology, 2007
- Depression rating scales in Parkinson's disease: Critique and recommendationsMovement Disorders, 2007
- A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometryJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Subtype of Mild Cognitive Impairment and Progression to Dementia and DeathDementia and Geriatric Cognitive Disorders, 2006
- Cognitive profiles of individual patients with Parkinson's disease and dementia: Comparison with dementia with lewy bodies and Alzheimer's diseaseMovement Disorders, 2006
- Discriminative and predictive power of an informant report in mild cognitive impairmentJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Effects of Depression and Parkinson's Disease on Cognitive FunctioningThe Journal of Neuropsychiatry and Clinical Neurosciences, 2002
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979